APIM050198: MK-1775 (ADAVOSERTIB) (AZD1775)
CAS No.: 955365-80-7.
Purity: >99.5% (HPLC).
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050216: PALBOCICLIB (PD-0332991) (FREE BASE)
CAS No.: 571190-30-2.
Purity: >99.8% by HPLC.
QC: HPLC, 1H-NMR, Quantitative Elemental Analysis Report.
Solubility: Soluble in 1N HCl, (22.4mg/ml, 50mM), at 45 oC.APIM050217: PALBOCICLIB (PD-0332991) (HCL SALT)
CAS No.: 827022-32-2
Purity: >99.5% (HPLC at 214 and 254 nm).
QC: HPLC, 1HNMR.
Solubility: Soluble in DMSO and water.APIM050218: PALBOCICLIB (PD-0332991) (ISETHIONATE SALT)
CAS No.: 827022-33-3.
Purity: >99% (HPLC at 214 and 254 nm).
QC: HPLC, MS, 1HNMR.
Solubility: Soluble in DMSO, Ethanol and Water.APIM050318: DOXORUBICIN
CAS No.: 23214-92-8.
Purity: 99% (HPLC).
QC: HPLC, 1HNMR, Quantitative Elemental Analysis.
Solubility: Soluble in water.C045P: Efalizumab Biosimilar, CD11a Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade efalizumab biosimilar specifically binds to the human CD11a.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by efalizumab.